News

Have you ever noticed your glasses prescription changing every few months, or felt like night driving has suddenly become a ...
Xpanceo raised a $250 million funding round, which elevates its valuation to $1.35 billion, as it pioneers smart contact ...
With integrated clinical, lab, and research teams onsite, BostonSight expands its capacity to support trials advancing the ...
Compared to Q1 2025, Bausch + Lomb increased its full-year revenue and adjusted EBITDA guidance. In Q1, revenue guidance was $5 billion to $5.1 billion; now, it is $5.05 billion to $5.15 billion. The ...
If you fall into the latter camp, good news is on the cards: you can throw away those infrared night-vision goggles, because ...
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
Alcon launched Tryptyr, a treatment for the signs and symptoms of dry eye disease, in the U.S. Tryptyr (acoltremon ophthalmic solution 0.003%) is a TRPM8 receptor agonist that showed a “statistically ...
Contact lens wearers with presbyopia can be successfully refit into daily disposable multifocal lenses, a study shows.
A team of scientists has developed contact lenses for infrared vision, allowing for human sight to expand beyond the limits ...